Chengcheng Fu

ORCID

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 6

Top Venues

Annals of hematology

American journal of hematology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Yingying Zhai, Lingzhi Yan, Song Jin, Shuang Yan, Weiqin Yao, Jingjing Shang, Xiaolan Shi, Ruju Wang, Huizhu Kang, Jing Lu, Ziling Zhu, Fang Tang, Feng Wei, Chengcheng Fu, Depei Wu
Autologous stem cell transplantation in multiple myeloma patients with renal impairment. Annals of hematology 102 (3) (2023)
Yingying Zhai, Lingzhi Yan, Song Jin, Shuang Yan, Weiqin Yao, Jingjing Shang, Xiaolan Shi, Ruju Wang, Huizhu Kang, Jing Lu, Ziling Zhu, Fang Tang, Feng Wei, Chengcheng Fu, Depei Wu
Autologous stem cell transplantation in multiple myeloma patients with renal impairment. Annals of hematology 102 (3) (2023)
Yingying Zhai, Lingzhi Yan, Song Jin, Shuang Yan, Weiqin Yao, Jingjing Shang, Xiaolan Shi, Ruju Wang, Huizhu Kang, Jing Lu, Ziling Zhu, Fang Tang, Feng Wei, Chengcheng Fu, Depei Wu
Autologous stem cell transplantation in multiple myeloma patients with renal impairment. Annals of hematology (2023)
Yingying Zhai, Lingzhi Yan, Song Jin, Shuang Yan, Weiqin Yao, Jingjing Shang, Xiaolan Shi, Ruju Wang, Huizhu Kang, Jing Lu, Ziling Zhu, Fang Tang, Feng Wei, Chengcheng Fu, Depei Wu
Autologous stem cell transplantation in multiple myeloma patients with renal impairment. Annals of hematology 102 (3) (2023)
Yifan Zhai, Qiuqiong Tang, Douglas D Fang, Jing Deng, Kaixiang Zhang, Qixin Wang, Yan Yin, Chengcheng Fu, Sheng-Li Xue, Na Li, Feng Zhou, Dajun Yang
Lisaftoclax in Combination with Alrizomadlin Overcomes Venetoclax Resistance in Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Preclinical Studies. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Xiaolan Shi, Ling-Zhi Yan, Jingjing Shang, Liqing Kang, Zhi Yan, Song Jin, Mingqing Zhu, Huirong Chang, Feiran Gong, Jiazi Zhou, Guanghua Chen, Jinlan Pan, Dandan Liu, Xiaming Zhu, Fang Tang, Minghong Liu, Wei Liu, Feirong Yao, Lei Yu, Depei Wu, Chengcheng Fu
Anti-CD19 and anti-BCMA CAR T cell therapy followed by lenalidomide maintenance after autologous stem-cell transplantation for high-risk newly diagnosed multiple myeloma. American journal of hematology 97 (5) (2022)

Chengcheng Fu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Chengcheng Fu